The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets, it said in a statement.
The company has received tentative approval from the US Food and Drug Administration (USFDA) for Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets, it said in a statement.